Brain Tumor Precision Medicine Conference
Neurosurgery conference room – 3898 Taubman (back of Neurosurgery dept. offices).
"Fenretinide as a novel therapeutic agent against DIPG" Dr. Maria Tsoli, the Preclinical Core Testing Team Leader at the Children's Cancer Institute in the University of New South Wales in Sydney, Australia
Please mark your calendars for the next UM Brain Tumor Precision Medicine conference – Friday, June 2nd, at 2 pm EST / 11 am PST – conference will last 1 to 1.5 hours. We will be teleconferencing (video) via BlueJeans and separate audio dial-in (1-734-997-7110 (3898#).